FAKTOR-OPTIONSSCHEIN - AMGEN | Market Closed - Boerse Frankfurt Warrants 01:08:46 15/06/2024 am IST | ||
| 1.49 EUR | 0.00% |
|
| Current month | -12.79% | ||
| 1 month | -26.11% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 14/24/14 | 1.5 | +0.67% |
| 13/24/13 | 1.49 | -3.25% |
| 12/24/12 | 1.54 | -2.53% |
| 11/24/11 | 1.58 | -5.95% |
| 10/24/10 | 1.68 | -2.33% |
Real-time Boerse Frankfurt Warrants
Last update June 15, 2024 at 01:08 am IST
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | 
Société Générale
|
| WKN | SB01UZ |
| ISIN | DE000SB01UZ8 |
| Date issued | 09/06/2020 |
| Strike | 225.4 $ |
| Maturity | Unlimited |
| Parity | 1 : 1 |
| Emission price | 8.83 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 19.24 € |
|---|---|
| Lowest since issue | 0.59 € |
| Spread | 0.02 € |
| Spread % | 1.31% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
298.6
USD
Average target price
316.4
USD
Spread / Average Target
+5.97%
- Stock Market
- Certificates
- Certificat
